Cambrios was formed in 2003 to develop commercial applications from the directed-evolution technology invented by the companys founders, Dr. Angela Belcher of MIT and her longtime collaborator, Dr. Evelyn Hu of the University of California at Santa Barbara. Cambrios holds exclusive license rights to Dr. BelcherТ’s technology and is dedicated to the rapid, high-value implementation of these new methods in a variety of applications.

Cambrios is an attractive partner for the electronics industry. Our directed-evolution technology platform is the first practical union of biology and electronics. By applying the techniques of molecular biology to the synthesis and assembly of commercially important materials, Cambrios is able to manufacture electronic components in completely new ways. When bundled with existing manufacturing processes, we believe our technology will enable higher performance at lower cost, and with less impact on the environment.

Cambrios' main business goal is to identify and develop key applications that are uniquely enabled by our technology. The application landscape the company plans to explore includes the synthesis of important materials, process agents for manufacturing, and preparation of nanostructures made of custom materials. In developing these applications, Cambrios looks to partner with innovative companies seeking breakthrough solutions to important commercial problems.